Managed Care



February 2001

Despite what might be commonly believed, pharmacoeconomics is not a widely used tool for formulary development. Here's a model to follow.
T. Jeffrey White, Pharm.D., M.S.
When it comes to information-sharing, just when does 'no' mean 'no'? What about conflicting statutes? We have two years to sort it out.
Michael Levin-Epstein
There's a difference between plausibility and wishful thinking that many who predict the advent of this system fail to recognize. Risk adjusting, adverse selection, and the tax code present hurdles.
Frank Diamond
While health plans have embraced alternative therapies, there's little agreement on how to bill for them. The ability to demonstrate outcomes may help.
Debra Gordon
Unintentional bias can be just as damaging as the overt brand, according to the president of the National Medical Association.
Patrick Mullen


4th Partnering With ACOs Summit Los Angeles, CA October 27–28, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015